Meloxicam leads to few stomach upsets

Key points
- Many people with arthritis and other painful conditions take non-steroidal anti-inflammatory drugs (NSAIDs) every day, which can cause stomach problems such as ulcers.
- "Our study showed that meloxicam 7.5 milligrams per day had a better gastrointestinal safety profile than diclofenac, piroxicam and naproxen," lead investigator Dr.
- Meloxicam is sold under the brand name Mobic by Boehringer-Ingelheim Pharmaceuticals Inc., which sponsored the study.
- As described in the American Journal of Medicine, Dr.
Many people with arthritis and other painful conditions take non-steroidal anti-inflammatory drugs (NSAIDs) every day, which can cause stomach problems such as ulcers. One of these drugs, meloxicam, seems to have an edge in this regard, according to a new study.
"Our study showed that meloxicam 7.5 milligrams per day had a better gastrointestinal safety profile than diclofenac, piroxicam and naproxen," lead investigator Dr. Gurkipal Singh told Reuters Health. "At a 15-milligram per day dose, it was statistically better than piroxicam."
Meloxicam is sold under the brand name Mobic by Boehringer-Ingelheim Pharmaceuticals Inc., which sponsored the study. Diclofenac, piroxicam and naproxen are known by various names, including Arthrotec and Voltaren (diclofenac); Feldene (piroxicam); and Anaprox or Naprosyn (naproxen).
As described in the American Journal of Medicine, Dr. Singh of Stanford University School of Medicine, California, and colleagues reviewed 28 NSAID studies involving 24,196 patients. Most participants were followed for up to 60 days.
In total 10,158 patients were given daily meloxicam at a dose of 7.5 milligrams (mg), 2960 received 15 mg; 5283 were given diclofenac at 100 mg, 181 received 150 mg; 5371 got piroxicam at 20 mg; and 243 received naproxen, 500 mg twice daily.
Patients given meloxicam 7.5 mg had a 0.03 percent risk of serious upper gastrointestinal side effects. This was significantly lower than the risk with any of the other NSAIDS. However, at 15-mg per day, meloxicam was only significantly safer than piroxicam.
While meloxicam seems better than the others, the researchers point out that "only a small number of patients were followed for more than 60 days."
SOURCE: American Journal of Medicine, July 15, 2004.
NEXIUM © is used to treat ulcers, esophagitis and other conditions due to acid secretion. It works by blocking the production of acid in the stomach.
Prevacid © is used to treat and prevent stomach and intestinal ulcers, erosive esophagitis (damage to the esophagus from stomach acid), and other conditions involving excessive stomach acid such as Zollinger-Ellison syndrome.
PRILOSEC © is used to treat various acid-related stomach and esophagus problems by blocking the production of acid in the stomach. Prilosec © may be right for you if you suffer from persistent heartburn.
Ranitidine HCL reduces the amount of acid in your stomach. It is used to treat and prevent ulcers, to treat gastroesophageal reflux disorder (GERD), and to treat conditions associated with excessive acid secretion.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Digestive Health →
NewsVaccine for Stomach Flu May be Possible
Every year, millions of people are infected with noroviruses - commonly called “stomach flu” – often resulting in up to 72 hours of vomiting and diarrhea. While most people recover in a few days, the symptoms can lead…
15 February 2008
NewsCoated Aspirin Has Same Effect on Stomach as Plain Aspirin
Some people take aspirin without ever having a problem with their stomach. Others develop low-grade stomach pain or get an ulcer. A few develop gastrointestinal bleeding severe enough to require a transfusion. But…
1 August 2007
NewsHelicobacter pylori increases risk of lower stomach cancer, decreases risk of upper
The bacteria Helicobacter pylori substantially increase the risk of cancer in the lower stomach, but it may decrease the risk of cancer near the junction between the esophagus and the stomach, according to a study in…
